ArticlePediatric surgery international2026
Analysis of neuromuscular blockade use and prognosis in resuscitation of isolated congenital diaphragmatic hernia: data from Japanese CDH Study Group.
Article in Pediatric surgery international, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
18 authors.
Funding
Abstract
purposeNeuromuscular blocking agents (NMBAs) may reduce lung compliance and affect long-term outcomes in congenital diaphragmatic hernia (CDH). This study investigated the association between NMBA use during CDH resuscitation and outcomes, including neurodevelopmental impairment (NDI) and sensorineural hearing loss (SNHL).
methodsWe retrospectively analyzed 438 isolated CDH cases from the Japanese CDH Study Group registry (2006–2021), comparing those who received NMBAs at 5 min post-birth with those who did not. Outcomes included mortality, hospital stay, weaning from ventilation, NDI, and SNHL at discharge and at 1.5, 3, and 6 years. Cox proportional hazards models assessed prognosis in prenatally classified mild and moderate-to-extreme groups.
resultsNMBA recipients (n = 138) had more severe prenatal findings, higher 5-min intubation rates, greater early oxygenation index, and longer hospital stays (55 vs. 46 days, p < 0.01). Mortality was higher but not significant (19% vs. 13%, p = 0.09). Adjusted hazard ratios for NDI and SNHL showed no significant associations overall or by severity group.
conclusionsNMBA use in CDH resuscitation was not significantly associated with mortality, NDI, or SNHL. Further studies evaluating NMBA duration and cumulative exposure are needed to clarify its potential impact on outcomes.
Indexed as
Identifiers
41954655What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.